• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

143
19
13
13
11

COUNTRY

5
4
4
4
3

PRICE

86
119
288
510

PUBLISHED

0
14
129
510

PRODUCT TYPE

504
3
2
1

Immune Disorders

(510 Products)

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

Bone Marrow Transplantation - Pipeline Review, H1 2015

Bone Marrow Transplantation - Pipeline Review, H1 2015 Summary This, ‘Bone Marrow Transplantation - Pipeline Review, H1 2015’, provides an overview of the Bone Marrow Transplantation’s therapeutic...

March 2015
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

March 2015
FROM

Anca Vasculitis - Pipeline Review, H1 2015

Anca Vasculitis - Pipeline Review, H1 2015 Summary This, ‘Anca Vasculitis - Pipeline Review, H1 2015’, provides an overview of the Anca Vasculitis’s therapeutic pipeline. This report provides comprehensive...

March 2015
FROM

Corneal Graft Rejection - Pipeline Review, H1 2015

Corneal Graft Rejection - Pipeline Review, H1 2015 Summary This, ‘Corneal Graft Rejection - Pipeline Review, H1 2015’, provides an overview of the Corneal Graft Rejection’s therapeutic pipeline. This...

March 2015
FROM

Pollen Allergy - Pipeline Review, H1 2015

Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Pollen Allergy’s therapeutic pipeline. This report provides comprehensive...

March 2015
FROM

Myasthenia Gravis Global Clinical Trials Review, H1, 2015

Myasthenia Gravis Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2015" provides data on the Myasthenia Gravis clinical...

March 2015
FROM

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The lupus therapeutics market is dominated by generics...

February 2015
FROM

Sarcoidosis - Pipeline Review, H1 2015

Sarcoidosis - Pipeline Review, H1 2015 Summary This ‘Sarcoidosis - Pipeline Review, H1 2015’, provides an overview of the Sarcoidosis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Grass Pollen Allergy - Pipeline Review, H1 2015

Grass Pollen Allergy - Pipeline Review, H1 2015 Summary This ‘Grass Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Grass Pollen Allergy’s therapeutic pipeline. This...

February 2015
FROM

Pemphigus - Pipeline Review, H1 2015

Pemphigus - Pipeline Review, H1 2015 Summary This ‘Pemphigus - Pipeline Review, H1 2015’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides comprehensive information...

February 2015
FROM

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015 Summary This, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

January 2015
FROM

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

January 2015
FROM

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

January 2015
FROM

Birch Pollen Allergy - Pipeline Review, H1 2015

Birch Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Birch Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Birch Pollen Allergy’s therapeutic pipeline. This report...

January 2015
FROM

Cat Allergy - Pipeline Review, H1 2015

Cat Allergy - Pipeline Review, H1 2015 Summary This, ‘Cat Allergy - Pipeline Review, H1 2015’, provides an overview of the Cat Allergy’s therapeutic pipeline. This report provides comprehensive information...

February 2015
FROM
Analysis of Barclays plc Analysis of Barclays plc - Product Thumbnail Image

Analysis of Barclays plc

Barclays Plc is a major global financial services company based in London. In 2010, the company was measured as being the tenth largest banking and financials services company in the world by Forbes....

February 2015
FROM

House Dust Mite Allergy - Pipeline Review, H1 2015

House Dust Mite Allergy - Pipeline Review, H1 2015 Summary This, ‘House Dust Mite Allergy - Pipeline Review, H1 2015’, provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This...

January 2015
FROM

Ragweed Allergy - Pipeline Review, H1 2015

Ragweed Allergy - Pipeline Review, H1 2015 Summary This, ‘Ragweed Allergy - Pipeline Review, H1 2015’, provides an overview of the Ragweed Allergy’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM
Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape - Product Thumbnail Image

Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Summary "Gene Therapy Immunology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles...

January 2015
FROM

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity...

December 2014
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare